BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 37494056)

  • 1. Long-Term Survival, Prognostic Factors, and Selection of Patients With Colorectal Cancer for Liver Transplant: A Nonrandomized Controlled Trial.
    Dueland S; Smedman TM; Syversveen T; Grut H; Hagness M; Line PD
    JAMA Surg; 2023 Sep; 158(9):e232932. PubMed ID: 37494056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Potential Role of Liver Transplantation as a Treatment Option in Colorectal Liver Metastases.
    Line PD; Hagness M; Dueland S
    Can J Gastroenterol Hepatol; 2018; 2018():8547940. PubMed ID: 29623266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation for colorectal liver metastasis.
    Line PD; Dueland S
    Curr Opin Organ Transplant; 2024 Feb; 29(1):23-29. PubMed ID: 37995153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Patients With Colorectal Liver Metastasis in the Developing World: Is Liver Transplantation for Unresectable Liver Metastasis, the Next Logical Step?
    M J; Kazi M; Patkar S; S PR; Bhoyar A; Desouza A; Saklani A; Goel M
    J Clin Exp Hepatol; 2023; 13(5):753-759. PubMed ID: 37693265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation as an alternative for the treatment of non-resectable liver colorectal cancer: Advancing the therapeutic algorithm.
    Rawashdeh B; Bell R; Hakeem A; Prasad R
    Hepatobiliary Pancreat Dis Int; 2024 Apr; 23(2):154-159. PubMed ID: 38182479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transplant Oncology: An Emerging Discipline of Cancer Treatment.
    Abdelrahim M; Esmail A; Abudayyeh A; Murakami N; Victor D; Kodali S; Cheah YL; Simon CJ; Noureddin M; Connor A; Saharia A; Moore LW; Heyne K; Kaseb AO; Gaber AO; Ghobrial RM
    Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Outcomes of Liver Transplantation for the Management of Neuroendocrine Neoplasms: A Systematic Review.
    Palaniappan V; Li CH; Frilling A; Clift AK
    J Pers Med; 2023 Sep; 13(10):. PubMed ID: 37888039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Festina lente-to advance we need to make haste slowly. Living donor liver transplant for colorectal cancer liver metastases.
    Hernandez-Alejandro R; Chávez-Villa M; Line PD; Sapisochin G
    Am J Transplant; 2024 Apr; 24(4):517-519. PubMed ID: 37769711
    [No Abstract]   [Full Text] [Related]  

  • 9. Living Donor Liver Transplantation for Hepatocellular Carcinoma Within and Outside Traditional Selection Criteria: A Multicentric North American Experience.
    Ivanics T; Claasen MPAW; Samstein B; Emond JC; Fox AN; Pomfret E; Pomposelli J; Tabrizian P; Florman SS; Mehta N; Roberts JP; Emamaullee JA; Genyk Y; Hernandez-Alejandro R; Tomiyama K; Sasaki K; Hashimoto K; Nagai S; Abouljoud M; Olthoff KM; Hoteit MA; Heimbach J; Taner T; Liapakis AH; Mulligan DC; Sapisochin G; Halazun KJ;
    Ann Surg; 2024 Jan; 279(1):104-111. PubMed ID: 37522174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical application of circulating tumour DNA in colorectal cancer.
    Loft M; To YH; Gibbs P; Tie J
    Lancet Gastroenterol Hepatol; 2023 Sep; 8(9):837-852. PubMed ID: 37499673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avelumab vs Standard Second-Line Chemotherapy in Patients With Metastatic Colorectal Cancer and Microsatellite Instability: A Randomized Clinical Trial.
    Taïeb J; Bouche O; André T; Le Malicot K; Laurent-Puig P; Bez J; Toullec C; Borg C; Randrian V; Evesque L; Corbinais S; Perrier H; Buecher B; Di Fiore F; Gallois C; Emile JF; Lepage C; Elhajbi F; Tougeron D;
    JAMA Oncol; 2023 Oct; 9(10):1356-1363. PubMed ID: 37535388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical Appraisal of Guideline Recommendations on Systemic Therapies for Advanced Hepatocellular Carcinoma: A Review.
    Cappuyns S; Corbett V; Yarchoan M; Finn RS; Llovet JM
    JAMA Oncol; 2024 Mar; 10(3):395-404. PubMed ID: 37535375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facilitation of Definitive Cancer Diagnosis With Quantitative Molecular Assays of BRAF V600E and TERT Promoter Variants in Patients With Thyroid Nodules.
    Fu G; Chazen RS; Monteiro E; Vescan A; Freeman JL; Witterick IJ; MacMillan C
    JAMA Netw Open; 2023 Jul; 6(7):e2323500. PubMed ID: 37505499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma surveillance - utilization, barriers and the impact of changing aetiology.
    Huang DQ; Singal AG; Kanwal F; Lampertico P; Buti M; Sirlin CB; Nguyen MH; Loomba R
    Nat Rev Gastroenterol Hepatol; 2023 Dec; 20(12):797-809. PubMed ID: 37537332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abdominal Pain After Roux-en-Y Gastric Bypass: A Review.
    Fry BT; Finks JF
    JAMA Surg; 2023 Oct; 158(10):1096-1102. PubMed ID: 37531117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Prognostic Model To Predict Survival After Recurrence Among Patients With Recurrent Hepatocellular Carcinoma.
    Moazzam Z; Alaimo L; Endo Y; Lima HA; Woldesenbet S; Rueda BO; Yang J; Ratti F; Marques HP; Cauchy F; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Guglielmi A; Hugh T; Aldrighetti L; Shen F; Endo I; Pawlik TM
    Ann Surg; 2024 Mar; 279(3):471-478. PubMed ID: 37522251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updates and Expert Opinions on Liver Transplantation for Gastrointestinal Malignancies.
    Shannon AH; Ruff SM; Schenk AD; Washburn K; Pawlik TM
    Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy with or without selective internal radiation therapy for intrahepatic cholangiocarcinoma: Data from clinical trials.
    Edeline J; Bridgewater J; Campillo-Gimenez B; Neveu E; Phelip JM; Neuzillet C; Boudjema K; Rolland Y; Valle JW; Garin E; Malka D; Lamarca A
    Hepatology; 2024 Jan; 79(1):96-106. PubMed ID: 37505216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Senescence-based colorectal cancer subtyping reveals distinct molecular characteristics and therapeutic strategies.
    Lv MY; Cai D; Li CH; Chen J; Li G; Hu C; Gai B; Lei J; Lan P; Wu X; He X; Gao F
    MedComm (2020); 2023 Aug; 4(4):e333. PubMed ID: 37502611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathologic Lymph Node Regression After Neoadjuvant Chemotherapy Predicts Recurrence and Survival in Esophageal Adenocarcinoma: A Multicenter Study in the United Kingdom.
    Moore JL; Green M; Santaolalla A; Deere H; Evans RPT; Elshafie M; Lavery A; McManus DT; McGuigan A; Douglas R; Horne J; Walker R; Mir H; Terlizzo M; Kamarajah SK; Van Hemelrijck M; Maisey N; Sita-Lumsden A; Ngan S; Kelly M; Baker CR; Kumar S; Lagergren J; Allum WH; Gossage JA; Griffiths EA; Grabsch HI; Turkington RC; Underwood TJ; Smyth EC; Fitzgerald RC; Cunningham D; Davies AR;
    J Clin Oncol; 2023 Oct; 41(28):4522-4534. PubMed ID: 37499209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.